PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease
- 1 December 1990
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 27 (4) , 494-499
- https://doi.org/10.1002/jnr.490270409
Abstract
Striatal dopamine D‐1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early. Parkinson's disease using [11C]‐SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of [18F]‐6‐F‐DOPA in the striatum contralateral to the symptoms. None of the patients had received any antiparkinsonian medication. The striatal and cerebellar radioactivity was measured and corresponding striatum/cerebellum ratios were counted. The mean striatum/cerebellum ratio of [11C]‐SCH 23390 binding was symmetric be‐tween the hemispheres. By contrast, the striatum/cerebellum ratio of [11C]raclopride binding, labelling dopamine D‐2 receptors, was increased significantly in the hemisphere contralateral to the symptoms as compared with the opposite hemisphere. Thus, the present results show that the behaviour of striatal D‐1 and D‐2 receptors is different in early Parkinson's disease.Keywords
This publication has 26 references indexed in Scilit:
- Human dopamine receptor subtypes?in vitro binding analysis using3H-SCH 23390 and3H-racloprideJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Dopamine receptors in Parkinson's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopridePsychopharmacology, 1987
- Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological studyBrain Research, 1987
- Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptorsEuropean Journal of Pharmacology, 1986
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Central Dopaminergic Pathways in Hemiparkinsonism Examined by Positron Emission TomographyCanadian Journal of Neurological Sciences, 1984
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- ParkinsonismNeurology, 1967